Changes	Source	NCIt Subset Code	FDA Subset Name	NCIt Concept Code	FDA Source Code	FDA Source PT	FDA Source Synonym(s)	FDA Source Definition	NCIt Definition	Parent Concept's NCIt Concept Code	Parent Concept's FDA Source Code	Parent Concept's FDA Source PT
C	FDA	C54450	Patient Problem Codes FDA CDRH	C26715	1768	CELLULITIS			Inflammation of the dermis and subcutaneous tissues caused by a bacterial infection. Symptoms include erythema, edema, and pain to the affected area.	C2890	1735	INFECTION, BACTERIAL
C	FDA	C54450	Patient Problem Codes FDA CDRH	C3045	1862	FISTULA			Abnormal epithelial-lined communication between two anatomical structures.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C3133	1925	IMPOTENCE			Persistent or recurrent inability to achieve or to maintain an erection during sexual activity.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C35498	2108	TOXIC SHOCK SYNDROME	SHOCK SYNDROME (TSS), TOXIC|SYNDROME (TSS), TOXIC SHOCK|TOXIC SHOCK SYNDROME, (TSS)|TSS, TOXIC SHOCK SYNDROME	A severe illness caused by infection with staphylococcus aureus and characterized by high fever of sudden onset, vomiting, diarrhea, and myalgia, followed by hypotension and in severe cases, shock; a sunburn-like rash with peeling of the skin, especially of the palms and soles, occurs during the acute phase.	A rare acute life-threatening systemic bacterial noncontagious illness caused by any of several related staphylococcal exotoxins. It is characterized by high fever, hypotension, rash, multi-organ dysfunction, and cutaneous desquamation during the early convalescent period. The toxins affect the host immune system, causing an exuberant and pathological host inflammatory response. Laboratory findings include leukocytosis, elevated prothrombin time, hypoalbuminemia, hypocalcemia, and pyuria.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C36173	2475	PROLAPSE			A condition in which an organ or body tissue drops or bulges out of place.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50461	2491	AORTIC DISSECTION	DISSECTION, AORTIC		A progressive tear in the tissue lining the aorta, characterized by the passage of blood from the tunica intima into, and partially through, the tunica media.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50539	2363	DYSKINESIA		Difficulty moving; distortion or impairment of voluntary movement, as in tic, spasm, or myoclonus.	Abnormality or impairment of voluntary movement.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50623	2421	IRRITABILITY			Excited response to stimuli.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50666	1974	NEONATAL DEFORMITIES	DEFORMITIES, NEONATAL		A congenital anatomic abnormality manifested during the neonatal period.	C2849	1782	CONGENITAL DEFECT/DEFORMITY
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50739	2069	SEROMA		A tumor-like collection of serum in the tissues.	A collection of serum in the body.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50759	1894	HEMORRHAGE, SUBDURAL	SUBDURAL HEMORRHAGE	Cerebral hemorrhage into the subdural space. See also Stroke Syndrome.	Bleeding between the dura mater and the brain, usually secondary to a tear of the bridging vein.	C26791	1888	HEMORRHAGE
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50761	2603	HEMORRHAGE, SUBGALEAL	HEMORRHAGE, SUBGALEAL		Bleeding between the scalp and the periosteum.	C26791	1888	HEMORRHAGE
C	FDA	C54450	Patient Problem Codes FDA CDRH	C50850	1990	OVERSEDATED			A level of sedation that is greater than the intended level.	C54027	2688	PATIENT PROBLEM/MEDICAL PROBLEM